Literature DB >> 2489029

Interaction of a permeant maleimide derivative of cysteine with the erythrocyte glucose carrier. Differential labelling of an exofacial carrier thiol group and its role in the transport mechanism.

J M May1.   

Abstract

S-(Bismaleimidomethyl ether)cysteine (Cys-Mal) was synthesized as a probe for reactive thiol groups on the erythrocyte glucose carrier. Although Cys-Mal entered cells, its reaction with intracellular GSH prevented alkylation of endofacial membrane proteins, limiting its effect to the cell surface at concentrations below 5 mM. Cys-Mal irreversibly inhibited hexose transport half-maximally at 1.5 mM by decreasing the maximal rate of transport, with no effect on the affinity of substrate for the carrier. Reaction occurred with the outward-facing form of the carrier, but did not affect the ability of the carrier to change orientation. In intact cells, several exofacial proteins were labelled by [35S]Cys-Mal, including the band-4.5 glucose carrier, the labelling of which occurred on a single site sensitive to transport inhibitors. The reactive exofacial group was a thiol group, since both transport inhibition and band-4.5 labelling by Cys-Mal were abolished by the thiol-specific and impermeant compound 5,5'-dithiobis(2-nitrobenzoic acid). Selectivity for carrier labelling in cells was increased by a double differential procedure, which in turn allowed localization of the exofacial thiol group to the Mr 18,000-20,000 membrane-bound tryptic carrier fragment. In protein-depleted ghosts the exofacial thiol group was preferentially labelled at low concentrations of [35S]Cys-Mal, whereas with the reagent at 10 mM the Mr 26,000-45,000 tryptic carrier fragment was also labelled. Cys-Mal should be useful in the study of carrier thiol-group location and function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2489029      PMCID: PMC1133512          DOI: 10.1042/bj2630875

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

2.  A fluorometric method for determination of oxidized and reduced glutathione in tissues.

Authors:  P J Hissin; R Hilf
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

3.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.

Authors:  T L Steck; J A Kant
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Human erythrocyte sugar transport. Identification of the essential residues of the sugar carrier by specific modification.

Authors:  R Bloch
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

6.  Reactions of N-ethylmaleimide with peptides and amino acids.

Authors:  D G Smyth; O O Blumenfeld; W Konigsberg
Journal:  Biochem J       Date:  1964-06       Impact factor: 3.857

7.  Biochemical studies on the mode of action of cytochalasin B. Cytochalasin B binding to red cell membrane in relation to glucose transport.

Authors:  S Lin; J A Spudich
Journal:  J Biol Chem       Date:  1974-09-25       Impact factor: 5.157

8.  Impermeant maleimides. Oriented probes of erythrocyte membrane proteins.

Authors:  R E Abbott; D Schachter
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

Review 9.  The organization of proteins in the human red blood cell membrane. A review.

Authors:  T L Steck
Journal:  J Cell Biol       Date:  1974-07       Impact factor: 10.539

10.  LOCALIZATION OF ERYTHROCYTE MEMBRANE SULFHYDRYL GROUPS ESSENTIAL FOR GLUCOSE TRANSPORT.

Authors:  J VANSTEVENINCK; R I WEED; A ROTHSTEIN
Journal:  J Gen Physiol       Date:  1965-03       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.